Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May;6(3):138-46.
doi: 10.1177/2040622315579063.

Optimizing the use of thiopurines in inflammatory bowel disease

Rishi M Goel  1 , Paul Blaker  2 , Alex Mentzer  2 , Steven C M Fong  2 , Anthony M Marinaki  3 , Jeremy D Sanderson  2
Affiliations
Review

Optimizing the use of thiopurines in inflammatory bowel disease

Rishi M Goel et al. Ther Adv Chronic Dis. 2015 May.

Abstract

Immunomodulator drugs, of which thiopurines can be considered the backbone, are widely used in the treatment of inflammatory bowel disease. They have been shown to be highly effective and safe; however, a significant proportion of patients are deemed to have a poor response or suffer adverse reactions. Knowing how to monitor and optimize thiopurine therapy in these scenarios is crucial to effective management. We discuss the metabolism of thiopurines, the use of enzyme/metabolite testing to guide treatment, as well as strategies to circumvent toxicity and side effects, such as allopurinol coprescription. The indications, use in pregnancy, safety profile and duration of thiopurine therapy are also discussed.

Keywords: Crohn’s disease; azathioprine; drugs; gastroenterology; inflammatory bowel disease; thiopurines; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare no conflict of interest in preparing this article.

Figures

Figure 1.
Figure 1.
A simplified schematic of the thiopurine metabolic pathway. AO, aldehyde oxidase; AZA, azathioprine; MeMP, methylmercaptopurine; MP, mercaptopurine; TGMP, thioguanine monophosphate; TGN, thioguanine nucleotide; TIMP, thioinosine monophosphate; TPMT, thiopurine-S-methyltransferase; TUA, thiouric acid; XDH, xanthine dehydrogenase.
Figure 2.
Figure 2.
When to measure thioguanine nucleotides and blood test monitoring. FBC, full blood count; MeMP, methylmercaptopurine; S/Es, side effects; TGN, thioguanine nucleotide; TPMT, thiopurine-S-methyltransferase.
See this image and copyright information in PMC

References

    1. Aarbakke J., Janka-Schaub G., Elion G. (1997) Thiopurine biology and pharmacology. Trends Pharmacol Sci 18: 3–7. - PubMed
    1. Amin J., Huang B., Yoon J., Shih D. (2015) Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD. Inflamm Bowel Dis 21: 445–452. - PubMed
    1. Ansari A., Hassan C., Duley J., Marinaki A., Shobowale-Bakre E., Seed P., et al. (2002) Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Aliment Pharmacol Ther 16: 1743–1750. - PubMed
    1. Ansari A., Patel N., Sanderson J., O’Donohue J., Duley J., Florin T. (2010) Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse reactions in patients with inflammatory bowel disease. Aliment Pharmacol Ther 31: 640–647. - PubMed
    1. Aridizzone S., Maconi G., Russo A., Imbesi V., Colombo E., Bianchi Porro G., et al. (2006) Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 55: 47–53. - PMC - PubMed

LinkOut - more resources